What is psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Psoriasis

Psoriasis is a chronic, genetic, systemic inflammatory disease characterized by well-demarcated, erythematous (red) plaques with silvery scale, most commonly affecting the scalp, elbows, knees, and presacral region. 1

Core Disease Characteristics

Psoriasis is fundamentally a multisystem inflammatory disorder that extends beyond the skin, affecting approximately 2% of the population worldwide. 1 The disease results from inappropriate activation of cutaneous T cells and dendritic cells with subsequent release of inflammatory cytokines and mediators. 1

Pathophysiology

  • Accelerated keratinocyte turnover is the hallmark cellular abnormality, with the epidermal cell reproduction cycle shortened from the normal 28 days to approximately 4 days, resulting in immature cell deposition and characteristic scaling. 2

  • Immune dysregulation involves complex interplay between Th1/Th2 homeostasis, the Th17/Treg balance, and the IL-23/Th17 axis, with Th17 cells playing a particularly critical role in creating an integrated inflammatory loop with dendritic cells and keratinocytes. 3

  • Genetic predisposition is significant, with susceptibility linked to HLA-Cw6 (PSORS1), though environmental factors can alter disease expression. 1, 4

Clinical Presentation

Classic Plaque Psoriasis (Psoriasis Vulgaris)

  • Well-demarcated plaques with thick silvery scale on an erythematous base are the defining features. 1

  • Common locations include scalp, extensor surfaces (elbows, knees), presacral region, though any skin area may be involved including palms, soles, nails, and genitalia. 1

  • Pruritus and pain are frequent symptoms that significantly impact quality of life. 1

Other Clinical Variants

  • Guttate psoriasis presents as dew-drop-like, 1-10 mm salmon-pink papules with fine scale, primarily on trunk and proximal extremities, most common in individuals under 30 years. 1

  • Inverse psoriasis affects skin folds (axillary, genital, perineal, intergluteal, inframammary areas) with erythematous plaques and minimal scale due to moisture. 1

  • Pustular psoriasis shows clinically apparent collections of neutrophils, ranging from localized palmoplantar involvement to generalized von Zumbusch variant with fever and systemic toxicity. 1

  • Erythrodermic psoriasis involves generalized erythema covering nearly the entire body surface with varying degrees of scaling, potentially causing thermoregulatory dysfunction, hypothermia, and dehydration. 1

Disease Severity Classification

Severity is defined by body surface area (BSA) involvement: less than 3% BSA is mild, 3-10% BSA is moderate, and greater than 10% BSA is severe disease. 1

Critical caveat: Psoriasis can be severe irrespective of BSA when it causes serious emotional consequences, occurs in high-impact locations (hands, feet, scalp, face, genitals), or causes intractable pruritus. 1

Systemic Associations and Comorbidities

Psoriatic arthritis develops in 30-33% of adult patients with psoriasis, making it a member of the seronegative spondyloarthropathies. 1, 4

Cardiovascular and metabolic complications are significantly increased, including:

  • Diabetes and metabolic syndrome components 1, 4
  • Cardiovascular disease and coronary artery disease 1, 4
  • Nonalcoholic fatty liver disease 1

Other immune-mediated associations include inflammatory bowel disease (Crohn's disease 3.8-7.5 times more frequent), lymphoma, and multiple sclerosis. 1, 4

Disease Course

Psoriasis is a chronic, lifelong condition that waxes and wanes throughout the patient's lifetime, is modified by treatment initiation and cessation, and has few spontaneous remissions. 1 The visible and disfiguring nature of the disease ensures significant physical and psychosocial effects on patients. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Psoriasis: characteristics, psychosocial effects and treatment options.

British journal of nursing (Mark Allen Publishing), 2010

Research

The Inflammatory Response in Psoriasis: a Comprehensive Review.

Clinical reviews in allergy & immunology, 2016

Guideline

Psoriasis and Eczema Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.